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ABSTRACT
The emergence of the novel COVID-19 pandemic has had a signifi-
cant impact on global healthcare and the economy over the past few
months. The virus’s rapid widespread has led to a proliferation in
biomedical research addressing the pandemic and its related topics.
One of the essential Knowledge Discovery tools that could help the
biomedical research community understand and eventually find a
cure for COVID-19 are Knowledge Graphs. The CORD-19 dataset is
a collection of publicly available full-text research articles that have
been recently published on COVID-19 and coronavirus topics. Here,
we use several Machine Learning, Deep Learning, and Knowledge
Graph construction and mining techniques to formalize and extract
insights from the PubMed dataset presented in [8] and the CORD-
19 dataset [1] to identify COVID-19 related experts and bio-entities.
Besides, we suggest possible techniques to predict related diseases,
drug candidates, gene, gene mutations, and related compounds as
part of a systematic effort to apply Knowledge Discovery methods
to help biomedical researchers tackle the pandemic.
CCS CONCEPTS
• Applied computing → Health informatics; Biological net-
works; • Computing methodologies → Information extrac-
tion; Knowledge representation and reasoning; • Informa-
tion systems→ Information systems applications;
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1 INTRODUCTION
1.1 Knowledge Graphs
A Knowledge Graph (KG) is a graph-based data structure used to
represent unstructured information so that a machine can read
it. Emerging from Knowledge Bases, KGs now represent a ubiqui-
tous set of methods for representing and integrating knowledge in
various domains. A KG contains descriptions of entities and their
relationships as information in the form of first-order logical facts
such as <Mount Fuji is located in Japan> that can be retrieved and
queried heuristically. KGs emerged to power what was known in
the eighties and the nineties as Expert Systems - an early form
of Artificial Intelligence and Decision Support Systems [25]. The
number of entity types and relationships in a KG is finite and is
usually but not necessarily organized in a schema or an ontology.
In 2012 Google introduced the Google Knowledge Graph [21], a
technology that converts multiple information sources to a graph
structure where the nodes represent real-life entities and types.
The edges represent the relationships between those entities and
types, and the technology was aimed at enhancing the users’ search
experience through predicting the users’ search intent and intro-
ducing a Knowledge Panel on the right of page [21]. Knowledge
Graph technology today has been adopted in many domains and
fields to store, integrate, and represent unstructured information
in a structured format that is more flexible and machine-readable
than the traditional entity-relationship data model [6].
Other examples of widely used and adopted KGs in different
domains such as Social Networks and Life Sciences include the
Facebook Social Graph [30] and Chem2Bio2RDF [5]. The advance-
ment of KG construction and mining was powered by the already
established research fields of Machine Learning, Deep Learning,
Graph Mining, and Complex Networks. The techniques and meth-
ods developed by researchers in such fields are used to mine data
and information in KGs to extract insights crucial to advancing
knowledge in various domains. Research in Information Networks
also played a role in the construction and mining of KGs mainly
through relying on statistical methods and machine learning tech-
niques [28]. Information networks are widely heterogeneous graphs
of nodes and edges representing meta-information about a pub-
lished corpus of literature such as authors, papers, publications,
and venues. Hence, information networks are KGs in which graph
mining techniques can be applied to extract insights about author
collaboration patterns and their topics of interest. Mining informa-
tion networks as KGs has to lead to understanding trends such as
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collaboration patterns and potential drug re-purposing opportuni-
ties in a specific domain without reading the entire literature in a
field.
KGs have been curated manually, yet, over the years, KG con-
struction techniques have changed. For example, Cyc [18] is a KG
that was manually curated, while Freebase [3] and Wikidata [32]
were crowd-sourced. KGs can also be extracted using Natural Lan-
guage Processing (NLP) techniques such as in DBpedia [17] and
YAGO [27]. Alternatively, KGs can be constructed using a combi-
nation of manual curation and automatic extraction like in NELL
[4] and Knowledge Vault [11]. Regardless of the approach of how
a KG has been constructed, KGs need to be queried and mined to
map complex real-world phenomena and eventually be exploited
to solve important research questions. For example, Facebook’s
Social Graph needs to be mined to suggest new friends for users.
Life Sciences KGs like Chem2Bio2RDF need to be mined to answer
research questions related to biomedical science.
1.2 Named Entity Recognition in Knowledge
Graph Construction
The move towards natural language understanding through se-
mantic technologies has gained much ground in the past decade,
promoting Named Entity Recognition (NER) to a central NLP task.
NER has been crucial for building and constructing KGs as the
primary method of extracting entities and possibly relations from
free text. Also, tasks such as link prediction, relation extraction,
and graph completion on KGs are aided by NER. NER can be im-
pactful when applied to mine domain-specific scientific literature
such as the biomedical literature to extract bio entities aiding in
constructing KGs and advancing downstream knowledge discovery
tasks in biomedicine.
Although research in NER has been advancing since the nineties
[20], early efforts in domain-specific biomedical NER came later in
the early 2000s [26]. Those methods in biomedical NER relied on
feature engineering and graphical models such as Hidden Markov
Models (HMM) and Conditional Random Fields (CRF) [26]. When
applying CRF models to the biomedical text, the objective is to
construct a chain out of the words then predict the assigned labels
based on a conditionally trained finite state machine where the
probability of each label assigned to a word is correlated with a
feature set. The objective was then to maximize the log-likelihood
of the label given the word directly. The accuracy of the recogni-
tion of bioentities in CRF and HMM models were quite low when
compared to state of the art today. The current state of the art
relies on the latest in Deep Learning in contextual embedding such
as BERT. BERT is a deep learning model developed in [9] by a
team at Google to be fine-tuned for machine translation tasks. The
model was based on the transformer architecture described in [31].
Multiple attention heads are used to train a contextual embedding
where the task is to predict masked words of the input sentences.
The sophisticated inner architecture of BERT based on multiple
encoder-decoder layers allows for learning high-quality embedding
from a large corpus of data where the learned weights can be later
transferred and fine-tuned to downstream tasks. In [16], the authors
trained a BERT model on the corpus of PubMed and PMC named
BioBERT. The result was a biomedical contextual embedding model
that was later fine-tuned and used in a biomedical NER task pro-
ducing high accuracy tagging and extraction of bio entities such
as drugs, diseases, and genes. The high accuracy of the BioBERT
model allowed and aided in the construction of the PubMed KG
presented in [33].
1.3 The COVID-19 Knowledge Graph
Several months amid the emergence of the acute respiratory syn-
drome COVID-19 caused by the novel coronavirus Sars-CoV-2 in
China, the disease has risen to a global pandemic level affecting
almost every country on earth and infecting more than 6 million
people across the globe and killing more than 350000 [2]. As a re-
sult, researchers from every domain have reoriented their efforts
towards finding ways and solutions to tackle the pandemic. Specifi-
cally, the biomedical literature on COVID-19 and SARS-CoV-2 and
other related acute respiratory syndromes that have reached an epi-
demic level such as SARS and MERS have increased exponentially
since the virus’s appearance back in December 2019. As a result,
government-backed calls and research institutions like the Allen
Institute for AI have released a COVID-19 Open Research Dataset
CORD-19 [1]. The dataset contains over 65000 full-text scholarly
articles related to COVID-19, SARS-CoV-2, and other related topics.
This effort aims to encourage the NLP and KG researcher commu-
nity to mine the dataset to generate insights through text mining
techniques and methods to help point biomedical researchers in
the right direction to fight against the virus.
We see the release of the CORD-19 dataset of machine-readable
scientific literature as an opportunity to extract a comprehensive
and cohesive COVID-19 KG of the entities and relationships though
cooccurrence within the corpus of articles. The extracted KG will
help understand the relationships between the diseases, the genes,
the viruses, and the cures involved in and related to COVID-19 so
that future graph and network mining efforts can be applied to
extract insights from the dataset. Here we present our vision in
contributing to that effort.
We demonstrate methods of entity extraction and KG building
to harvest a COVID KG capable of being a useful dataset for future
mining in the hope that it will help biomedical researchers find
a cure and tackle the pandemic through generating deep insights.
We first introduce how to use BioBERT for named entity recogni-
tion in the PubMed and CORD-19 datasets. Then we built several
Coronavirus Knowledge Graphs based on two different kinds of
measurements. One measure the relationship between source node
and each target node based on co-occurrence frequency. The other
is to use Cosine Similarity to measure the similarity between the
source node and each target node.
2 RELATEDWORK
Previous efforts and trials to build a comprehensive COVID-19 KG
have lacked in several areas. For example [10] built a COVID-19
related KG based on 145 articles and provided a web application for
ease of use and access. This COVID-19 KG contains 3954 nodes and
9484 relations, covering ten entity types. It reveals host-pathogen
interactions, comorbidities, symptoms, and discovered over 300
candidate drugs for COVID-19. Nevertheless, the effort was limited
in terms of the number of publications included in constructing the
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KG. [12] applied a machine learning model (BERE [14]) to integrate
and mine KG to also aide in the effort of identifying candidate drugs
for COVID-19. Besides, [24] used a pre-built KG for COVID-19 drug
discovery and identified the drug "baricitinib" to protect lung cells
from being infected by the virus. Previously mentioned efforts
though promising, yet they lacked the large scale KG construction
and mining approaches necessary to extract more profound and
in-depth insights about the disease and possible cures, treatments,
and genetic influences.
NLP techniques have also been utilized outside of the KG con-
struction arena, for example, [29] introduced CovidQA, a question
answering dataset, which comprises 124 questions and answers of
triples built by hand from knowledge collected from the CORD-19
dataset. [13] developed a self-supervised context-aware COVID-19
document exploration based on BERT. [19] used BERT to analyze a
large collection of COVID-19 literature from the CORD-19 dataset
[15] to extract COVID-19 related radiological findings. Though rig-
orous in using large datasets such as CORD-19, the previous NLP
techniques were limited in terms of applications and the impact of
those applications on the COVID-19 oriented biomedical research
field.
3 DATASETS
3.1 PubMed dataset
The PubMed database contains more than 30 million citations
within the various fields of life sciences. The PubMed citation data-
base archived by the MEDLINE archive has always been the desired
datasets for biomedical text and graph mining research communi-
ties.
We select PubMed dataset because it is a popular dataset in
biomedical area and reflect general biomedical knowledge.
3.2 The PubMed Knowledge Graph
[33] built a PubMed KG which connects disambiguated author
names, their articles, and bio-entities using the PubMed database
were they parsed 29 million PubMed abstracts from 1781 till 2019. In
addition to funding extracted from the National Institutes of Health
using ExPORTER, and affiliations were extracted from ORCID and
MapAffil.
3.3 The CORD-19 Dataset
The CORD-19 dataset was released in response to COVID-19, where
the US Government has issued requests for research groups and
institutions to combine efforts to release the COVID-19 Open Re-
search Dataset (CORD-19). The datasets contain more than 135000
articles with over 68000 full texts on topics related to Coronavirus
and the COVID-19 pandemic. The data set was released to help the
biomedical research community by applying the latest in NLP to
extract deep insights and understandings of the pandemic patterns
and the possible drugs, cures, and genes that might be involved and
identified [1].
Here we perform our analysis on the entities and relationships
extracted from the three datasets and we show the potential in
knowledge discovery.
4 EXPERIMENT-0 IDENTIFY EXPERTS ON
CORONAVIRUS TOPICS
We would like to identify the experts for COVID to encourage
collaboration. To do that, we analyzed COVID-19 44k dataset and
ranked the researchers according to the number of articles they
published in the COVID-19 44K dataset. Part of the results are
shown in Table 1.
Table 1: COVID-19 related researchers
Author # of articles publishedin COVID-19 dataset
Perlman, Stanley 142
Drosten, Christian 137
Yuen, Kwok-Yung 136
Baric, Ralph S 132
Jiang, Shibo 120
Enjuanes, Luis 116
Snijder, Eric J 104
Weiss, Susan R 92
5 EXPERIMENT-1 NAMED ENTITY
RECOGNITIONWITH BIOBERT
5.1 Model
BERT (Bidirectional Encoder Representations from Transformers)
[9] is a highly influential Natural Language Processing model that
proposed back in 2018. BERT was inspired by many advanced Deep
Learning models, such as semi-supervised sequence learning[7],
ELMo [23] and the Transformer architecture [31].
The input representation of BERT is the sum of a token em-
bedding using WordPiece, a segmentation embedding indicating
whether each token belongs to sentence A or sentence B, and a
position embedding. A [CLS] flag is added before the first word of
the sentence, and a [SEP] flag is added as a separator token.
BERT has two tasks for pre-training: Masked Language Model
task and Next Sentence Prediction task. Considering most of tradi-
tional NLP model, instead of training a left-to-right or right-to-left
model based on the input language, it is better to use the bidirec-
tional model. However, the bidirectional model is not suitable for
the conditional task. Thus, inspired by the Cloze task, a masked
language model is adapted as the first task for BERT pre-training.
The second task for BERT pre-training is Next Sentence Prediction
(NSP), which allows the model to understand sentence relation-
ships.
BioBERT (Bidirectional Encoder Representations from Trans-
formers for Biomedical Text Mining) [16] is a biomedical language
representation model based on BERT [9]. It is proposed because
directly adapting BERT to text mining in the biomedical area was
not promising, given the word shift from generic domain to the
biomedical domain. BioBERT is pre-trained on PubMed abstracts
and PubMed Central full-text articles (PMC).
We select BioBERT-Base v1.1 (+PubMed 1M) based on the BERT-
base-Cases model. For our fine-tuning section, we fine-tuned it on
the NCBI disease dataset. The input to the BioBERT model is a
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Table 2: Named Entity Recognition using BioBERT in
PubMed dataset
Word Label
Asymptomatic O-MISC
carrier O-MISC
state O-MISC
, O-MISC
acute B-MISC
respiratory I-MISC
disease I-MISC
, O-MISC
and O-MISC
pneumonia B-MISC
due O-MISC
to O-MISC
severe O-MISC
acute B-MISC
respiratory I-MISC
syndrome I-MISC
coronavirus I-MISC
2 I-MISC
( O-MISC
SARSCoV O-MISC
- O-MISC
2 O-MISC
) O-MISC
: O-MISC
Facts O-MISC
and O-MISC
myths O-MISC
sentence embedded following BERT’s embedding process. Parts of
the token-level evaluation looks like: "[CLS]Ang ##iot ##ens ##in
- converting enzyme 2 (AC ##E ##2 ) as a SA ##RS - Co ##V - 2
receptor: molecular mechanisms and potential therapeutic target.
[SEP]". The output of this model will be a sentence with labels.
Label "B-MISC" means the Begining of bioentities, "I-MISC" means
Insdie the bio entities, and "O-MISC" means Outside the bio entity.
We tested BioBERT on PubMed KG and the CORD-19 dataset.
5.2 Results
Examples of entity-level recognized names from the PubMed dataset
are shown in Table 2. The recognized bio-entities are "acute res-
piratory disease", "pneumonia", and "acute respiratory syndrome
coronavirus 2". "SARSCOV-2" should, but is not recognized as bio-
entities.
Since we do not have detailed labels for BioBERT fine-tuning
training and thus cannot predict detailed labels directly fromBioBERT.
To get more detailed labels, we trained a Random Forest model on
around 100,000 PubMed bio-entities labeled with five categories:
species, gene, diseases, drug, gene mutation, and tested on the bio-
entities recognized by BioBERT. The F1-score is shown in Table
3. The F1-Score of disease, gene, and drug recognition are all over
75%. However, the model poorly predicts when it comes to label
Table 3: Specific named entity classification using Random
Forest
Label Precision Recall F1-Score Data Size
Species 0.72 0.31 0.43 15519
Disease 0.94 0.61 0.74 12077
Gene 0.95 0.64 0.76 18678
Drug 0.66 0.99 0.79 53523
Gene mutation 0.5 0.17 0.25 36
Table 4: named entity Recognition using BioBERT in
COVID-19 44K dataset
Word Label
Thrombocytopenia O-MISC
is O-MISC
associated O-MISC
with O-MISC
severe O-MISC
coronavirus B-MISC
disease I-MISC
2019 I-MISC
COVID B-MISC
- I-MISC
19 I-MISC
infections O-MISC
A O-MISC
meta O-MISC
- O-MISC
analysis O-MISC
"Species" and labels "Gene mutation," probably because the dataset
was very unbalanced (Gene mutation only has 17 samples, and
Species has only 1395 samples).
Examples of named entity recognized from CORD-19 44K dataset
are shown in Table 4. In the example, the recognized bio-entities are
"coronavirus disease 2019", and "COVID-19". "Thrombocytopenia,"
a kind of disease, should, but is not recognized. From these cases,
we find that BioBERT does not perform greatly, despite its high
accuracy. It may be because BioBERT can easily recognize the easy
and common bio-entities with a high occurrence rate but fail to
recognize rare biomedical terms.
6 EXPERIMENT-2.1 CO-OCCURRENCE
FREQUENCY BASED KNOWLEDGE GRAPH
6.1 Method
We used Gephi to build the co-occurrence frequency based Knowl-
edge Graph. Co-occurrence frequency is an above-chance frequency
of occurrence of two entities from an article. The data is from
the PubMed Knowledge Graph. For each target node (related bio-
entities), we calculated the times it shows up with the source
node and treat the times(co-occurrence frequency) as target node’s
weight. The higher the co-occurrence frequency, the closer the
target node is to the source node.
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Figure 1: remdesivir related disease KG based on co-
occurrence frequency
6.2 Result
Figure 1 and Figure 2 shows remdesivir centered KGs. In Figure 1,
the source node is remdesivir and the target nodes are remdesivir
related disease. As shown, “ COVID-19", “Ebola", “SARS", “EVD",
“MERS", “EBOV", “cytokine storm", “acute cardiac injury", and “
ARDS" are related to remdesivir. In Figure 2 the source node is
remdesivir and the target nodes are remdesivir related drugs from
PubMed bio-entity knowledge graph. The edge’s weights are based
on co-occurrence frequency. As shown, “favipiravir" (used for in-
fluenza), “ritonavir" (used for HIV), “lopinavir (used for HIV)", “rib-
avirin" (used for severe lung infections), “chloroquine" (used for
lupus, malaria, and rheumatoid arthritis), and “pyrazofurin", which
has antibiotic, antiviral and anti-cancer properties with severe side
effects, are remdesivir related drugs.
We also generated other 6 drug-centered KGs. The 6 drugs are
favipiravir, ritonavir, lopinavir, ribavirin, tamiflu, and umifenovir.
The diseases highly related to favipiravir are: Ebola, influenza,
Epstein-Barr virus, HBV infection, CCHF, avian influenza, hem-
orrhagic fever, Lassa fever, thrombocytopenia syndrome, Rift Val-
ley fever, and etc. The drugs highly related to favipiravir are: rib-
avirin, tamiflu, peramivir, amantadine, laninamivir, BCX4430, T-
1105, Pyrazine, and etc.
The diseases highly related to ritonavir are: HIV, AIDS, hepatitis
C virus, cirrhosis, nausea, and etc. The drugs highly related to
ritonavir are: lopinavir, indinavir, darunavir, lamivudine, atazanavir,
nelfinavir, and etc.
The diseases highly related to lopinavir are: HIV, AIDS, car-
diovascular disease, lipodystrophy, hepatitis C, diarrhea, malaria,
nausea, and etc. The drugs highly related to lopinavir are: ritonavir,
saquinavir, abacavir, nucleoside, indinavir, lamivudine, darunavir,
atazanavir, nelfinavir, tenofovir, nevirapine, zidovudine, amprenavir,
and etc.
Figure 2: remdesivir related drugKG based on co-occurrence
frequency
The diseases highly related to ribavirin are: HIV, HCC, cirrho-
sis, hepatitis, liver cirrhosis, liver transplantation, AIDS, RSV, de-
pression, chronic diseases, and etc. The drugs highly related to
ribavirin are: telaprevir, ledipasvir, alanine, sofosbuvir, boceprevir,
PEG, daclatasvir, simeprevir, ritonavir, paritaprevir, ombitasvir, and
dasabuvir.
The diseases highly related to tamiflu are: influenza, avian in-
fluenza, CCHF, pneumonia, HBV infection, cough, headache, hy-
pernatremia, fever, and etc. The drugs highly related to tamiflu
are: amantadine, zanamivir, amino acid, oseltamivir, carboxylaterib-
avirin, oseltamivir Phosphate, Peramivir, rimantadine, and lani-
namivir.
The diseases highly related to umifenovir are: influenza, acute
respiratory infections, viral infections, pneumonia, fever, andmepati-
tis B virus (HBV) infection. The drugs highly related to umifenovir
are tamiflu, rimantadine, ribavirin, ingavirin, amantadine, ARB,indole,
Zanamivir, Triazavirin, Reaferon, and etc.
Figure 3, Figure 4, and Figure 5 show two corona virus diseases
(SARS, MERS) and Ebola centered KG, respectively. Figure 3 shows
that SARS’s highly related diseases are acuate respiratory distress
syndrome, fever, influenza, HIV-1, Osteonecrosis, allergic inflam-
mation, lung disease, atypical pneumonia, allergic rhinitis, cough,
and etc. SARS’s highly related genes/chemicals are CD8+, CD4+,
TNF-alpha, interferon-gamma, IFN-alpha, IL8, lgG, C-reactive pro-
tein, S protein, lactate dehydrogenase, ACE2 gene, and etc. SARS’s
highly related drugs are ribavirin, methylpredinisolone, and corti-
costeroids, and etc.
Figure 4 shows that MERS’s highly related diseases are Severe
Acute Respiratory Syndrome, PRCV infection, and influenza.MERS’s
highly related drugs aremacrolides, ribavirin, azithromycin, lopinavir,
and nitonavir. MERS’s highly related genes/chemicals are CD26, S
protein gene, amino peptidase N, and etc.
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Figure 3: SARS centered KG based on co-occurrence fre-
quency
Figure 4: MERS centered KG based on co-occurrence fre-
quency
Figure 5 shows that Ebola’s highly related diseases are hem-
orrhagic fever, hyperthermia, malaria, and mosquito-borne infec-
tions. MERS’s highly related drugs are favipiravir and amodiaquine.
MERS’s highly related genes/chemicals are CD8+, CD4, DC-SIGN,
CD317, GP2, IFN-g, IRF3, RBBP6, and etc.
Figure 6 shows Angiotensin-converting enzyme 2 (ACE2) cen-
tered Knowledge Graph. ACE2 is an enzyme, which lowers blood
pressure by catalysing the hydrolysis of angiotensin II into an-
giotensin (1-7). ACE2 is the receptor that COVID-19 uses to infect
lung cells. It also serves as receptor for other coronaviruses such as
HCoV-NL63, SARS-CoV. As shown, ACE2’s related genes/chemicals
are renin, RAS, angiotensin, insulin, Mas receptor, vascular endothe-
lial growth factor-A, and etc. ACE2’s related diseases are diabetes,
hypertensive, chagas disease, severe acute respiratory syndrome-
associated coronavirus. ACE2’s related drugs are streptozotocin,
nitric-oxide, and aldosterone .ACE2’s related gene mutations are
“rs2106809" and “rs2074192".
Figure 5: Ebola centered KG based on co-occurrence fre-
quency
Figure 6: ACE2 centered KG based on co-occurrence fre-
quency
From the results we believe the PubMed Knowledge Graph is
very promising. However, this kind of KG has a entity name dis-
ambiguation issue. For example, “Favipiravir" could also be shown
as “favipiravir". Another case is “ACE-2", which is the abbreviation
of Angiotensin-converting enzyme 2. Besides, the co-occurrence
frequency cannot reflect the relationship between the source node
and the target node well. For example, if “A has nothing to do with
B" mentioned lots of times in different documents, its co-occurrence
frequency will be very high.
7 EXPERIMENT-2.2 COSINE SIMILARITY
BASED KNOWLEDGE GRAPH
7.1 Method
To deal with problems with co-occurrence frequency based KG, we
first normalized the entity using some human designed rules to deal
with entity name disambiguation issue. We mainly focus on case
sensitive, singular and plural, and disambiguation. For example,
“SIAsNN" will be normalized as "siann" and“respiratory illnesses"
will be normalized as "respiratory illness". Then we used Word2Vec
to convert the normalized entity to vector with length of 100. We
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Figure 7: favipiravir-centered KG (related chemical) based
on cosine similarity
then use Cosine Similarity to measure the similarity between the
source node and each target node. The Cosine Similarity is defined
as follows:
cos(S,T) = ST∥S∥∥T∥ =
∑n
i=1 SiTi√∑n
i=1 (Si )2
√∑n
i=1 (Ti )2
(1)
The KG based on cosine similarity is also built using Gephi
software.
7.2 Results
Figure 7 shows part of the favipiravir-centered knowledge graph
(chemical related). The source node is favipiravir and the target
node are related chemicals. The edge is cosine similarity relations.
The closer the target node is to the source node, the similar the
target node is to the source node. As shown, the top 10 chemical
related to favipiravir are guanine, csa, lysine, nh2, titanium, proline,
methicillin, anthraquinone, rimantadine, polyacrylamide. Figure
8 shows part of the favipiravir-centered knowledge graph (gene
related). As shown, the top 10 gene related to favipiravir are gm csf,
abortion, rig i, isg15, csa, akt, mtor, p53, th1, p38, tgf beta.
We also generate other 5 drug-centered KGs based on cosine simi-
larity. The top 10 chemicals related to lopinavir are retinoic acid, nu-
cleoside, tyr, glutamine, ribavirin, glycyrrhizin, co2, lopinavir, phos-
phonate, lymphoma, ifitm3. The top 10 genes related to lopinavir
are neuraminidase, p53, eif2alpha, apod, ribavirin, infection, cox-2,
ifitm3, iron.
The top 10 chemicals related to ribavirin are glycyrrhizin, lactate,
corticosteroid, coronavirus, steroid, nucleoside, ribavirin, sodium,
glucose, infection, oxygen, calcium, obesity. The top 10 genes re-
lated to ribavirin are toxicity, p53, swine, fibrosis, iron, neuraminidase,
diabetes, ribavirin, anemia, inflammation, infection.
Figure 8: favipiravir-centered KG (related gene) based on co-
sine similarity
The top 10 chemicals related to ritonavir are atp, ritonavir, cy-
clophosphamide, mtt, toxicity, sialic acid, sds, encephalitis, superox-
ide, sucrose, ethanol. The top 10 genes related to ritonavir are jnk,
p53, rig i, encephalitis, rnase l, stat3, toxicity, akt, neuraminidase,
stat1.
The top 10 chemicals related to tamiflu are superoxide, pred-
nisolone, flavonol, proline, nitric oxide, thymidine, glycyrrhizin,
propidium iodide, nitrogen, aspirin, tamiflu. The top 10 genes re-
lated to tamiflu are il-10, cd44, eif2alpha, tgf beta1, tlr2, ifn, cxcl10,
tumor necrosis factor tnf)-alpha, ire1, ccl2, tbk1.
The top 10 chemicals related to umifenovir are: tacrolimus, alkyl,
carbon monoxide, ca(2, cd, nucleolin, cytosine, glycyrrhizic acid, 2’-
o, umifenovir, prostaglandin e2. The top 10 genes related to umifen-
ovir are parp, pd l1, monocyte chemoattractant protein-1, nef, cxcr4,
cd45, nucleolin, dc ign, annexin v, cd19, mmp-2.
8 DISCUSSION AND CONCLUSION
In this research, we first used BioBERT to recognize entities in the
PubMed and the CORD-19 dataset. Our results show thatmost of the
recognized entities are strictly biomedical. Most of the recognized
entities in the CORD-19 dataset are disease lacking diversity in
entity types due to a lack in finding a suitable bio-medical training
dataset with detailed labeled bio-entity. For future work, we will
explore more other bio-medical dataset and try other biomedical
NLP models for named entity recognition, e.g., blueBERT [22].
Furthermore, we introduced the construction of Coronavirus
Knowledge Graph based on two different methods: co-occurence
frequency and cosine similarity. We explored and revealed that the
drug candidates recommended by drug-centered KG are promising.
We will consult experts in COVID-related research to verify our
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Figure 9: auto drug profiling example
drug-centered KG and conduct a more in-depth analysis for future
work.
Also, we aim to build a wider COVID related KG, connecting all
COVID related bio-entities rather than small drug/disease-centered
KG. The extracted KG will help understand the relationships be-
tween the diseases, the genes, the viruses, and the cures involved
in and related to COVID-19.
Finally, we hope to build an automatic profiling system to gener-
ate expert, drug, or disease profiling. The expected disease profiling
will look like Figure 9, which includes description, related bio enti-
ties (drugs, gene, protein, species), topic distribution, related experts,
organization, and featured publications.
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